AS Latvijas Juras medicinas centrs

MUN:UOM Stock Report

Market Cap: €5.4m

AS Latvijas Juras medicinas centrs Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for AS Latvijas Juras medicinas centrs.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth27.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

Jun 23
AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

Jun 06
Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Jun 01
A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Feb 17
Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

Dec 24
Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as AS Latvijas Juras medicinas centrs has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

MUN:UOM - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202410-100N/A
6/30/202410000N/A
3/31/202410002N/A
12/31/202310-1-12N/A
9/30/202310003N/A
6/30/20239002N/A
3/31/20239001N/A
12/31/202210101N/A
9/30/2022101-11N/A
6/30/2022101-11N/A
3/31/2022101-10N/A
12/31/202191-10N/A
9/30/20219101N/A
6/30/20218001N/A
3/31/20217001N/A
12/31/20207001N/A
9/30/20207001N/A
6/30/20207001N/A
3/31/20207000N/A
12/31/20197000N/A
9/30/20197000N/A
6/30/20197000N/A
3/31/20197001N/A
12/31/20187011N/A
9/30/20186011N/A
6/30/201860N/A1N/A
3/31/201860N/A0N/A
12/31/201761N/A0N/A
9/30/201760N/A0N/A
6/30/201760N/A0N/A
3/31/201760N/A0N/A
12/31/201660N/A0N/A
9/30/201660N/A1N/A
6/30/201660N/A1N/A
3/31/201660N/A1N/A
12/31/201560N/A0N/A
9/30/201561N/A0N/A
6/30/201561N/A0N/A
3/31/201561N/A0N/A
12/31/201451N/A1N/A
9/30/201450N/A0N/A
6/30/201450N/A1N/A
3/31/201450N/A1N/A
12/31/201350N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if UOM's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if UOM's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if UOM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if UOM's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if UOM's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if UOM's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y